U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499258) titled 'Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence' on March 24.
Brief Summary: Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.
Study Start Date: May 01
Study Type: OBSERVATIONAL
Condition:
Fecal Incontinence
Intervention:
DEVICE: Axonics SNM System INS Model 5101 (R20)
Participants treated with the rechargeable Axonics SNM System Model 5101 also referred to as R20. Commercial devices used in this study are within their intended use as described in each ...